Paul G. Sleph

Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors.

G. J. Grover, Paul G. Sleph, Steven Dzwonczyk · Circulation · 1992 · 258 citations · Full text

Medicine, Cardiology, Pharmacology +17

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Gary J. Grover, Steven Dzwonczyk, Diane M. McMullen et al. · Journal of Cardiovascular Pharmacology · 1995 · 258 citations

Medicine, Cardiology, Pharmacology +14

Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability

Gary J. Grover, Karin Mellström, Ye Liu et al. · Proceedings of the National Academy of Sciences · 2003 · 223 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.

G. J. Grover, John R. McCullough, D E Henry et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 177 citations

Medicine, Cardiology, Pharmacology +15

Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils

Todd G. Kirchgessner, Paul G. Sleph, Jacek Ostrowski et al. · Cell Metabolism · 2016 · 164 citations · Full text

Life Sciences, Molecular Medicine, Pharmacology +17